European Pharmaceutical Review

SEPTEMBER 5, 2023

million to establish a Medicines Manufacturing Skills Centre of Excellence. Enhancing talent in pharmaceutical manufacturing “Talent and skills are fundamental to successful innovation and industry growth. The UK government is investing £5.5

Medicine 98

Medicine Manufacturing Biopharma Pharmaceutical manufacturing 98

European Pharmaceutical Review

MAY 31, 2023

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. While the COVID-19 pandemic depleted demand for some medicines, the year-end saw widely-reported shortages of many medicines. billion, representing a significant waste of capacity and resources.

Management 111

Management Pharma Pharmaceutical manufacturing Medicine 111

European Pharmaceutical Review

APRIL 18, 2023

billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceutical manufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control.

Pharma 130

Pharma Pharmaceutical manufacturing Manufacturing Pharmaceutical 130

European Pharmaceutical Review

NOVEMBER 29, 2023

This step is important as these countries are key markets for pharmaceuticals manufacturing. Based on data on sales/value-based shares from various companies for APIs and Chemicals, India and China are estimated to account for up to half of materials for medicines, the Sustainable Markets Initiative (SMI) noted.

Manufacturing 107

Manufacturing Marketing Pharma Pharmaceutical manufacturing 107

PharmaTech

AUGUST 15, 2022

What actions can we as manufacturers take to make a difference to sustainability without disrupting the supply of our life-saving medicines?

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 52

PM360

AUGUST 26, 2024

Now, precision medicine needs an overhaul. During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. How can a newly expanded definition of precision medicine help? Today, they have implemented the precision medicine approach across 90% of their portfolio.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

European Pharmaceutical Review

OCTOBER 6, 2023

The Indian Pharmacopoeia Commission (IPC) is now a member the Pharmacopoeial Discussion Group (PDG). Thus, a key aim for the PDG is to harmonise select pharmacopoeial standards.

Medicine 105

Medicine Pharmaceutical manufacturing Manufacturing Pharmaceutical 105

Pharmaceutical Technology

FEBRUARY 27, 2025

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

Manufacturing 66

Manufacturing Pharmaceutical manufacturing Medicine Pharma 66

European Pharmaceutical Review

JULY 25, 2022

As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

European Pharmaceutical Review

JANUARY 16, 2023

Under the agreement with the Swiss Confederation (Switzerland), the Swiss Agency for Therapeutic Products (Swissmedic) and the US Food and Drug Administration (FDA) will be able to utilise each other’s GMP inspections of pharmaceutical manufacturing facilities, avoiding the need for duplicate inspections.

Food and Drug Administration 122

Food and Drug Administration FDA Manufacturing Food 122

Pharmaceutical Technology

JUNE 7, 2023

The funding will support the new production plant and distribution hub, which is aimed at enhancing access to high-quality medicines in Africa. The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs.

Manufacturing 96

Manufacturing Pharma Distribution Pharmaceutical products 96

European Pharmaceutical Review

JULY 5, 2024

This follows publication of its Manifesto , which detailed recommendations such as increasing patient access to new treatments through clinical trials and enhancing the pharmaceutical manufacturing in the UK.

Pharma 98

Pharma Government Safety Medicine 98

European Pharmaceutical Review

SEPTEMBER 14, 2023

This increases renewable energy capacity to the national gas grid.

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Manufacturing 104

Manufacturing Pharmaceutical manufacturing Distribution Medicine 104

European Pharmaceutical Review

MAY 23, 2024

concluded that the advantages MM-IJ3DP for “in-batch manufacturing of different designs, combined with the controlled release of the active pharmaceutical ingredient (API) demonstrated here, offer realistic opportunities for advanced pharmaceutics manufacturing and personalised medicines”. Rivers et al.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Medicine Pharmaceutical 98

European Pharmaceutical Review

MAY 1, 2024

Our Ludwigshafen site serves as a centre of excellence for both research and development and pharmaceutical manufacturing and will play a critical role in AbbVie’s future growth,” stated Azita Saleki-Gerhardt , PhD, Executive Vice President, Chief Operations Officer. The new R&D building in Germany is expected to completed in 2027.

Pharmaceutical manufacturing 98

Pharmaceutical manufacturing Medicine Pharmaceutical Patients 98

European Pharmaceutical Review

NOVEMBER 9, 2023

AMR certification: recognising responsibly in antibiotic manufacture Addressing AMR risk in pharmaceutical manufacturing “This first-of-a-kind certification demonstrates that Sandoz… is taking the necessary steps to ensure responsible manufacturing of [generic antibiotic medicines] – a key pillar of the global AMR response strategy,” stated Boumediene (..)

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

NOVEMBER 10, 2023

“This important investment will ensure the continuous development of our late-phase pipeline into deliveries of important medicines for treatments to patients worldwide”, Wulff declared in the original annoucement.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

World of DTC Marketing

DECEMBER 10, 2020

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

DECEMBER 18, 2023

Additionally, in October, EPR shared Phase III trial data for the type 1 diabetes treatment TZIELD (Teplizumab), which suggested that the medicine could slow disease progression. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. megatonnes in the same year, and the increased demand and complexity of medicines since then will only have swollen this figure. 1 That’s more than the automotive sector, which released 46.4

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

European Pharmaceutical Review

NOVEMBER 24, 2023

The investment, which includes capacity for GLP-1 products, will “increase Novo Nordisk’s ability to meet future demands for innovative medicines.” The facility will support process development, good manufacturing practice (GMP) manufacturing, as well as product release.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

European Pharmaceutical Review

AUGUST 25, 2023

The European Commission (EC)’s revised Annex 1 – Manufacture of Sterile Medicinal Products is now effective in the EU. As of 25 August 2023, pharmaceutical manufacturers are required to implement the GMP regulation into cleaning and bio-decontamination procedures for these products.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Training 98

European Pharmaceutical Review

SEPTEMBER 26, 2022

Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. IDA Ireland is delighted to partner with AbbVie in creating these opportunities for new employees who will help write the next chapter in its story.”

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

MARCH 13, 2024

In the paper, the author acknowledged that topical medicinal products require the absence of bacterial species such as P. Conclusion Overall, the method facilitates the “timely monitoring of pharmaceutical preparations and resources to limit contamination throughout the pharmaceutical manufacturing process,” the author asserted.

Media 98

Media Medical Pharmaceutical manufacturing Pharmaceutical 98

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Manufacturing 97

Manufacturing Medicine Management Pharmaceutical 97

Pharmaceutical Technology

APRIL 18, 2023

The investment at the LEAP site marks the company’s biggest manufacturing investment at a single location to date. The new facilities will also support the company’s efforts to manufacture new therapeutic modalities, including genetic medicines. Last year, the company committed to providing $42.5m

Manufacturing 52

Manufacturing Food and Drug Administration Pharmaceutical manufacturing Medicine 52

PM360

JUNE 26, 2023

The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. For pharmaceutical manufacturing, many of these processes are subject to good manufacturing practice (GxP) and oversight by regulatory bodies. drug manufacturers to continue producing generic drugs.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

European Pharmaceutical Review

DECEMBER 12, 2023

In recent years, nitrosamines have been detected in various medicines, leading to voluntary product recalls from the market. Nitrosamines analysis is, thus, key to ensuring safety and quality in the pharmaceutical industry.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Safety Pharmaceutical Manufacturing 59

European Pharmaceutical Review

JULY 3, 2023

Reflecting on five years of quality control for nitrosamine impurities Warning Letters In FY2022, the FDA issued 72 CGMP-related warning letters to pharmaceutical manufacturing sites. Most that received warning letters (68 percent) were FDF manufacturers of non-sterile, non-application products.

Food and Drug Administration 105

Food and Drug Administration FDA Manufacturing Product sample 105

Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

pharmaphorum

OCTOBER 27, 2022

However, there is a general prohibition in the legislation of using celebrities to promote medicines. Amos-Stone assists companies on strategic issues arising during the life cycle of pharmaceutical products, including regulatory data protection, supplementary protection certificates, paediatric rewards, and orphan market exclusivity.

Media 98

Media Pharmaceutical Medicine Electronics 98

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

European Pharmaceutical Review

AUGUST 29, 2024

The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme is a joint initiative between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI).

Government 59

Government Pharma Competition Medicine 59

PM360

DECEMBER 20, 2023

Three Categories of Drugs Medicines entering the Chinese market will be classified into three categories: Category 1 refers to medicines listed on the “National Essential Medicine List” and are eligible for full reimbursement by BMI. The drugs in the list are both Western medicines and traditional Chinese medicines.

Marketing 105

Marketing Insurance Medical Manufacturing 105